Applied Therapeutics Inc (NASDAQ:APLT) currently has a daily average trading volume of 2.67M but it saw 3377790 shares traded in last market. With a market cap of 35.35M USD, the company’s current market price of $0.30 came falling about -7.43 while comparing to the previous closing price of $0.33. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.62 and as low as $0.30. In the recent trading on the day, stock has struck highest price mark of $0.295 while lowest mark touched by it was $0.325.
Taking a look at 20-day trading activity of Applied Therapeutics Inc (APLT) gives us an average price of $0.4382, while its current price level is -97.14% below from 52-week high level whereas it is 1.27% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5022 while that of 200 days or SMA-200 reads an average of $4.0909. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.52% during that period while stretching the period over a month that decreases to 12.49%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 31.03 which implies that the stock is in neutral territory.
UBS downgraded its recommendation for the stock as a “Neutral” from “Buy” on December 02, 2024 while assigning a price target range of $13-$2. RBC Capital Mkts also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $12 and $4.
Over the week, APLT’s stock price is moving -3.83% down while it is -41.66% when we observe its performance for the past one month. Year-to-date it is -64.52% down and over the past year, the stock is showing a downside performance of -94.00%.
The company is expected to be releasing its next quarterly report on 2025-Apr-13, for which analysts forecasted an EPS of -0.18 while estimate for next year EPS is -0.66. Moreover, analysts are in estimates of $10M for current-quarter revenue.
Currently, Applied Therapeutics Inc’s total number of outstanding shares is 137.23M with 6.47% of that held by the insiders while 107.28% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -177.83%. Stock’s beta reads 2.07. Stock has a price to book (P/B) ratio of 0.73 while price to sale or P/S ratio amounts to 76.85.
